Hemodialysis International | 2019
Using dalteparin in quotidian and nocturnal hemodialysis patients: A prospective study
Abstract
Introduction: Low‐molecular weight heparin, such as dalteparin, is an alternative anticoagulation method in conventional hemodialysis (HD). However, there are limited studies on its use in quotidian and nocturnal HD. We assessed the optimal dose, treatment efficacy, and patient safety of dalteparin in quotidian and nocturnal HD populations.